Interacting Drugs |
Ketoconazole (systemic) vs Paricalcitol |
Security Level |
 |
Mechanism |
Paricalcitol: CYP3A4 Inhibitors (Strong) may increase the serum concentration of Paricalcitol. |
Management |
Monitor therapy |
Ketoconazole (systemic) vs Paricalcitol
Post Review about Ketoconazole (systemic) vs Paricalcitol Click here to cancel reply.
Other Interactions of Ketoconazole (systemic)
Other Interactions of Paricalcitol
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.